Diamyd

Diamyd Uses, Dosage, Side Effects, Food Interaction and all others data.

Diamyd (recombinant human glutamic acid decarboxylase) is a vaccine being developed to treat insulin dependent type 1 diabetes.

The immune system of patients treated with Diamyd demonstrate an increase in the secretion of several immunomodulatory substances, dominated by regulatory cytokines, including IL5, IL13, IL10, IL17, IFN-a and TNF-a. Additionally, the activity of T-cells in response to GAD65 is increased with Diamyd therapy and subjects receiving Diamyd show an up regulation of cytokines in response to GAD65.

Trade Name Diamyd
Generic rhGAD65
rhGAD65 Other Names Recombinant human GAD65, Recombinant human glutamic acid decarboxylase
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Diamyd
Diamyd

Uses

Investigated for use/treatment in diabetes mellitus type 1.

Innovators Monograph

You find simplified version here Diamyd

*** Taking medicines without doctor's advice can cause long-term problems.
Share